# Silo Pharma, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:64c66462-ec91-4749-a23f-fdd19f82af65 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/silo-pharma-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 20 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-24T04:47:23.804732+00:00 | | Last reviewed | 2026-10-24T04:47:23.804732+00:00 | ## Identity - Legal name: Silo Pharma, Inc. - Display name: Silo Pharma, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-24T14:17:12.49533+00:00 | | Completeness | 0.409 | | Record Quality | 0.817 | | Directors | 4 | | Committees | 4 | | Governance events | 5 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Wayne D. Linsley: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Compensation · Chair; Nominating and Governance · Chair (member); Compensation (chair); Nominating and Governance (chair). claim_id=alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:leadership_role:6 - Dr. Jeff Pavell: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_record:9 - Dr. Kevin Muoz: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_record:9 - Eric Weisblum: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:leadership_role:5 ## Committees - Audit (audit). Chair: Wayne D. Linsley. Members: Wayne D. Linsley (chair, current); Dr. Jeff Pavell (member, current); Dr. Kevin Muoz (member, current). committee_id=alpha:committee:silo-pharma-inc:audit - Audit · Chair; Compensation · Chair; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Wayne D. Linsley (member, current). committee_id=alpha:committee:silo-pharma-inc:audit-chair-compensation-chair-nominating-and-governance-chair - Compensation (compensation). Chair: Wayne D. Linsley. Members: Wayne D. Linsley (chair, current); Dr. Jeff Pavell (member, current); Dr. Kevin Muoz (member, current). committee_id=alpha:committee:silo-pharma-inc:compensation - Nominating and Governance (nominating_governance). Chair: Wayne D. Linsley. Members: Wayne D. Linsley (chair, current); Dr. Jeff Pavell (member, current); Dr. Kevin Muoz (member, current). committee_id=alpha:committee:silo-pharma-inc:nominating-and-governance ## Executive leadership - Daniel Ryweck: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:leadership_role:7 - Eric Weisblum: Chairman, Chief Executive Officer, President, and Director [CEO]. Status: current. claim_id=alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:leadership_role:8 ## Governance events - CFO_CHANGED: Daniel Ryweck executive of Silo Pharma, Inc., effective 2026-03-27. Effective: 2026-03-27. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:hocfdq1fgoxe2 - CEO_CHANGED: Eric Weisblum executive of Silo Pharma, Inc., effective 2026-03-27. Effective: 2026-03-27. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:1bfwhiq1iy0vee - DIRECTOR_APPOINTED: Wayne D. Linsley seat on Silo Pharma, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:13vyyxq1cpfl26 - COMMITTEE_CREATED: Audit · Chair; Compensation · Chair; Nominating and Governance · Chair committee of Silo Pharma, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:1kvnvmu9uplfq - COMMITTEE_MEMBER_ADDED: Wayne D. Linsley member of Audit · Chair; Compensation · Chair; Nominating and Governance · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:e8euihly9bvj ## Scoped resources - `alpha://company/silo-pharma-inc` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record - `alpha://company/silo-pharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=identity - `alpha://company/silo-pharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=corporate-structure - `alpha://company/silo-pharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=board - `alpha://company/silo-pharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=committees - `alpha://company/silo-pharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=leadership - `alpha://company/silo-pharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=ownership - `alpha://company/silo-pharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=financials - `alpha://company/silo-pharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=capital-structure - `alpha://company/silo-pharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=compensation - `alpha://company/silo-pharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=governance - `alpha://company/silo-pharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=shareholder-governance - `alpha://company/silo-pharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=audit - `alpha://company/silo-pharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=legal - `alpha://company/silo-pharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=risk - `alpha://company/silo-pharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=cyber - `alpha://company/silo-pharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=ai-governance - `alpha://company/silo-pharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=agents - `alpha://company/silo-pharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=ecosystem - `alpha://company/silo-pharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=events - `alpha://company/silo-pharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=relationships - `alpha://company/silo-pharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=assessments - `alpha://company/silo-pharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:10: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:wayne-d-linsley","name":"Wayne D. Linsley"},"source_id":"board_seats"}` - Claim alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:11: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:dr-jeff-pavell","name":"Dr. Jeff Pavell"},"source_id":"board_seats"}` - Claim alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:12: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:dr-kevin-muoz","name":"Dr. Kevin Muoz"},"source_id":"board_seats"}` - Claim alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:wayne-d-linsley","name":"Wayne D. Linsley"},"source_id":"board_seats"}` - Claim alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:dr-jeff-pavell","name":"Dr. Jeff Pavell"},"source_id":"board_seats"}` - Claim alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:dr-kevin-muoz","name":"Dr. Kevin Muoz"},"source_id":"board_seats"}` - Claim alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:wayne-d-linsley","name":"Wayne D. Linsley"},"source_id":"board_seats"}` - Claim alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:dr-jeff-pavell","name":"Dr. Jeff Pavell"},"source_id":"board_seats"}` - Claim alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:dr-kevin-muoz","name":"Dr. Kevin Muoz"},"source_id":"board_seats"}` ## Leadership - Eric Weisblum: Director. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:96be493cefa8de8ed6b1772b9c362d31bc7f2ac81e0db8b84c10e673ee6eb8f7. - Wayne D. Linsley: Director, Audit · Chair; Compensation · Chair; Nominating and Governance · Chair. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:96be493cefa8de8ed6b1772b9c362d31bc7f2ac81e0db8b84c10e673ee6eb8f7. - Daniel Ryweck: Chief Financial Officer. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:leadership_role:7. Valid from: 2026-03-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:733fecc5759386983f32dbf3de6ca8a3021a6d360547bf677d5d9298329af9c0. - Eric Weisblum: Chairman, Chief Executive Officer, President, and Director. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:leadership_role:8. Valid from: 2026-03-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0fcd2cda897b52716aed21b0819f225724f02944ab923004381ec341da669f09. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Wayne D. Linsley; Members Wayne D. Linsley (Chair); Dr. Jeff Pavell; Dr. Kevin Muoz. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_record:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Compensation: Chair Wayne D. Linsley; Members Wayne D. Linsley (Chair); Dr. Jeff Pavell; Dr. Kevin Muoz. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Nominating and Governance: Chair Wayne D. Linsley; Members Wayne D. Linsley (Chair); Dr. Jeff Pavell; Dr. Kevin Muoz. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Silo Pharma, Inc.. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd97e4730a0dbf26300666b220c82466d46cb163afca4cf825e0cdae06368e5d. ## Entity Status - Public listing published. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd97e4730a0dbf26300666b220c82466d46cb163afca4cf825e0cdae06368e5d. ## Published Fact - US. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd97e4730a0dbf26300666b220c82466d46cb163afca4cf825e0cdae06368e5d. ## Committee Appointment - Wayne D. Linsley: chair, Audit. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Dr. Jeff Pavell: member, Audit. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Dr. Kevin Muoz: member, Audit. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Wayne D. Linsley: chair, Compensation. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Dr. Jeff Pavell: member, Compensation. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Dr. Kevin Muoz: member, Compensation. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Wayne D. Linsley: chair, Nominating and Governance. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Dr. Jeff Pavell: member, Nominating and Governance. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. - Dr. Kevin Muoz: member, Nominating and Governance. Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff. ## Security Listing - SILO (NASDAQ). Claim: alpha:claim:company:64c66462-ec91-4749-a23f-fdd19f82af65:security_listing:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd97e4730a0dbf26300666b220c82466d46cb163afca4cf825e0cdae06368e5d. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:cd97e4730a0dbf26300666b220c82466d46cb163afca4cf825e0cdae06368e5d: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/silo-pharma-inc). - alpha:projection-evidence:document:96be493cefa8de8ed6b1772b9c362d31bc7f2ac81e0db8b84c10e673ee6eb8f7: [Silo Pharma, Inc. DEF 14A 2025-09-05](https://www.sec.gov/Archives/edgar/data/1514183/000121390025085119/ea0255705-def14a_silo.htm). - alpha:projection-evidence:document:733fecc5759386983f32dbf3de6ca8a3021a6d360547bf677d5d9298329af9c0: [SILO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1514183/000121390026035576/ea0282804-10k_silo.htm). - alpha:projection-evidence:document:0fcd2cda897b52716aed21b0819f225724f02944ab923004381ec341da669f09: [SILO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1514183/000121390026035576/ea0282804-10k_silo.htm). - alpha:projection-evidence:8b4c344bf30f82ba73d33582f2f108eee93432562de301d1f5227e51a256b8ff: [Audit](https://www.sec.gov/Archives/edgar/data/1514183/000121390025085119/ea0255705-def14a_silo.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/silo-pharma-inc) - [Public Markdown](https://registry.alpha.ac/companies/silo-pharma-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/silo-pharma-inc?format=jsonld) - MCP resource: `alpha://companies/silo-pharma-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-24T14:17:12.26952+00:00; recorded 2026-10-24T14:17:12.26952+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.